search
Back to results

Cereset Research Long-Term Healthcare Worker Study (LT-HW)

Primary Purpose

Stress, Anxiety, Autonomic Dysregulation

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cereset Research
Sponsored by
Wake Forest University Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Stress focused on measuring stress, anxiety, insomnia, Cereset Research, hyperarousal, brain electrical activity, autonomic dysregulation, neurotechnology, HIRREM, allostasis, neuromodulation, acoustic stimulation, COVID-19, healthcare worker

Eligibility Criteria

18 Years - 100 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: Employed healthcare workers aged 18 years and older. Have availability and interest in participating in a 1 year study. Ability to comply with basic instructions and be able to sit still, comfortably during sessions. Experiencing symptoms of stress meeting threshold score on the Perceived Stress Scale (PSS ≥ 14). Exclusion Criteria: No internet access, as some visits collected electronically Unable, unwilling, or incompetent to provide informed consent. Physically unable to come to the study visits, or to sit still, comfortably in a chair for up to 1 hour. Severe hearing impairment (because the subject will be using ear buds during CR). Weight is over the chair limit (400 pounds). Currently enrolled in another active intervention research study. Prior use of: HIRREM, HIRREM-SOP, Brainwave Optimization (BWO), Cereset, Cereset Research, Cereset Home, or a wearable configuration of the same (B2, or B2v2). Prior use of the following modalities within one month before enrollment: electroconvulsive therapy (ECT), prior use of transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), alpha stimulation, eye movement desensitization and reprocessing (EMDR), brain spotting, neurofeedback, biofeedback, or deep brain stimulation (DBS). Known seizure disorder. Thoughts of active suicide within the last 3 months. Current medical student.

Sites / Locations

  • Atrium Wake Forest Baptist Health

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Other

Arm Label

Cereset Research Tune-Up Intervention Group

Cereset Research Control Group

Arm Description

All study participants will receive 4 initial CR sessions. Afterwards, they will be randomized, and this group will receive an additional tune-up (maintenance) session every 6 weeks for one year. There will be a CR session at weeks 6, 12, 18, 24, 30, 36, 42, and 48.

All study participants will receive 4 initial CR sessions. Afterwards, they will be randomized, and this group will continue their current care for 1 year with no additional CR sessions.

Outcomes

Primary Outcome Measures

Change in Perceived Stress Scale (PSS) scores
The Perceived Stress Scale (PSS) is a ten-item psychological instrument for measuring the perception of stress. It is a measure of the degree to which situations in one's life are appraised as stressful. Items were designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives. The scale, with answers rated from 0-4, also includes a number of direct queries about current levels of experienced stress. Higher scores suggest increase perceived stress.

Secondary Outcome Measures

Change in Insomnia Severity Index (ISI) scores
The severity of insomnia symptoms is measured using two self-report symptom inventories with each data collection visit. This includes the Insomnia Severity Index (ISI). The ISI is a 7-question measure, with responses from 0-4 for each question, yielding scores ranging from 0-28. The higher the score, the more suggestive of insomnia.
Change in Generalized Anxiety Disorder-7 (GAD-7) scores
The Generalized Anxiety Disorder-7 (GAD-7) is a seven-item screening tool for anxiety that is widely used in primary care. GAD-7 is a brief, reliable and valid measure of assessing generalized anxiety disorder. Higher scores suggest increased anxiety.

Full Information

First Posted
August 8, 2023
Last Updated
September 26, 2023
Sponsor
Wake Forest University Health Sciences
Collaborators
Susanne Marcus Collins Foundation, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05994261
Brief Title
Cereset Research Long-Term Healthcare Worker Study
Acronym
LT-HW
Official Title
Evaluating Long-Term Feasibility of Cereset Research for Stressed Healthcare Workers
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 2023 (Anticipated)
Primary Completion Date
October 2024 (Anticipated)
Study Completion Date
October 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wake Forest University Health Sciences
Collaborators
Susanne Marcus Collins Foundation, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Randomized, controlled study of long-term maintenance Cereset Research after an initial 4-session intervention bolus versus usual care control following an initial 4-session intervention bolus.
Detailed Description
This randomized, controlled study will evaluate the effects of long-term Cereset Research maintenance intervention in healthcare workers with symptoms of stress in the post era of COVID-19. Healthcare workers of all types have been impacted personally, professionally, and financially by the pandemic and its aftermath, resulting in higher levels of stress and anxiety. Additional, brief, noninvasive, non-drug strategies are needed to help mitigate the effects of the acute trauma associated with the pandemic. The primary outcome will be change in Perceived Stress Scale (PSS) a measurement of how different situations affect feelings and perceived stress in the Intervention group compared to the Control Group. Data will also be collected on a variety of additional relevant symptoms including insomnia, anxiety and autonomic cardiovascular regulation, for which benefits have been shown in prior studies using High-resolution, relational, resonance-based, electroencephalic mirroring (HIRREM). Data collected will assess the long-term effects of a low dose Cereset Research (CR) approach (only 4 sessions) and the importance of long-term maintenance intervention versus control. The Intervention Group will then receive 1 session every 6 weeks beginning 6 weeks after the 4 session bolus is completed. The Control Group continues current care with no additional CR sessions. A successful outcome of reduced stress at 1 year in the Intervention Group vs. Control Group would suggest benefit for long-term maintenance intervention sessions. The effect of this approach on autonomic function and other self-reported symptoms will also be explored. This information will be useful for determining intervention schedules for direct clinical implementation of the intervention. The proposed study might also help to identify characteristics of individuals who may experience differential effects/benefits from application of CR and determine if intermittent "tune-up" sessions may prolong symptom improvement.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stress, Anxiety, Autonomic Dysregulation, Acoustic Stimulation, Hyperarousal, Health Personnel
Keywords
stress, anxiety, insomnia, Cereset Research, hyperarousal, brain electrical activity, autonomic dysregulation, neurotechnology, HIRREM, allostasis, neuromodulation, acoustic stimulation, COVID-19, healthcare worker

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Randomized, controlled study of long-term maintenance Cereset Research after an initial 4-session intervention bolus versus usual care control following an initial 4-session intervention bolus.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
90 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cereset Research Tune-Up Intervention Group
Arm Type
Active Comparator
Arm Description
All study participants will receive 4 initial CR sessions. Afterwards, they will be randomized, and this group will receive an additional tune-up (maintenance) session every 6 weeks for one year. There will be a CR session at weeks 6, 12, 18, 24, 30, 36, 42, and 48.
Arm Title
Cereset Research Control Group
Arm Type
Other
Arm Description
All study participants will receive 4 initial CR sessions. Afterwards, they will be randomized, and this group will continue their current care for 1 year with no additional CR sessions.
Intervention Type
Device
Intervention Name(s)
Cereset Research
Intervention Description
The upgraded platform for medical research using the HIRREM technology has been rebranded as Cereset Research® (CR). This system uses the same core technology and algorithms to echo brainwaves in real-time using audible tones, as with HIRREM. The CR system also includes 64-bit processing architecture for faster feedback, the use of 4 sensors, and the use of standard protocols (with flexibility regarding the length and sequencing of the standard protocols), all done with eyes closed. Four sensors are applied to the scalp at a time. However, only two sensors are actively echoing feedback. The software automatically switches from one sensor pair to the other when needed. This reduces the number of sensor placement changes needed, resulting in shorter session time and fewer interruptions.
Primary Outcome Measure Information:
Title
Change in Perceived Stress Scale (PSS) scores
Description
The Perceived Stress Scale (PSS) is a ten-item psychological instrument for measuring the perception of stress. It is a measure of the degree to which situations in one's life are appraised as stressful. Items were designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives. The scale, with answers rated from 0-4, also includes a number of direct queries about current levels of experienced stress. Higher scores suggest increase perceived stress.
Time Frame
Baseline to year 1
Secondary Outcome Measure Information:
Title
Change in Insomnia Severity Index (ISI) scores
Description
The severity of insomnia symptoms is measured using two self-report symptom inventories with each data collection visit. This includes the Insomnia Severity Index (ISI). The ISI is a 7-question measure, with responses from 0-4 for each question, yielding scores ranging from 0-28. The higher the score, the more suggestive of insomnia.
Time Frame
Baseline to year 1
Title
Change in Generalized Anxiety Disorder-7 (GAD-7) scores
Description
The Generalized Anxiety Disorder-7 (GAD-7) is a seven-item screening tool for anxiety that is widely used in primary care. GAD-7 is a brief, reliable and valid measure of assessing generalized anxiety disorder. Higher scores suggest increased anxiety.
Time Frame
Baseline to year 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
100 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Employed healthcare workers aged 18 years and older. Have availability and interest in participating in a 1 year study. Ability to comply with basic instructions and be able to sit still, comfortably during sessions. Experiencing symptoms of stress meeting threshold score on the Perceived Stress Scale (PSS ≥ 14). Exclusion Criteria: No internet access, as some visits collected electronically Unable, unwilling, or incompetent to provide informed consent. Physically unable to come to the study visits, or to sit still, comfortably in a chair for up to 1 hour. Severe hearing impairment (because the subject will be using ear buds during CR). Weight is over the chair limit (400 pounds). Currently enrolled in another active intervention research study. Prior use of: HIRREM, HIRREM-SOP, Brainwave Optimization (BWO), Cereset, Cereset Research, Cereset Home, or a wearable configuration of the same (B2, or B2v2). Prior use of the following modalities within one month before enrollment: electroconvulsive therapy (ECT), prior use of transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), alpha stimulation, eye movement desensitization and reprocessing (EMDR), brain spotting, neurofeedback, biofeedback, or deep brain stimulation (DBS). Known seizure disorder. Thoughts of active suicide within the last 3 months. Current medical student.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Study Coordinator
Phone
336-716-9447
Email
BBRP@wakehealth.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Charles H Tegeler, MD
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Charles H Tegeler, MD
Organizational Affiliation
Wake Forest University Health Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Atrium Wake Forest Baptist Health
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27104
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Study Coordinator
Phone
336-716-9447
Email
BBRP@wakehealth.edu

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Cereset Research Long-Term Healthcare Worker Study

We'll reach out to this number within 24 hrs